1. Home
  2. IDYA vs CSTM Comparison

IDYA vs CSTM Comparison

Compare IDYA & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • CSTM
  • Stock Information
  • Founded
  • IDYA 2015
  • CSTM 2010
  • Country
  • IDYA United States
  • CSTM France
  • Employees
  • IDYA N/A
  • CSTM N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • CSTM Metal Fabrications
  • Sector
  • IDYA Health Care
  • CSTM Industrials
  • Exchange
  • IDYA Nasdaq
  • CSTM Nasdaq
  • Market Cap
  • IDYA 2.2B
  • CSTM 1.9B
  • IPO Year
  • IDYA 2019
  • CSTM 2013
  • Fundamental
  • Price
  • IDYA $24.27
  • CSTM $13.77
  • Analyst Decision
  • IDYA Strong Buy
  • CSTM Buy
  • Analyst Count
  • IDYA 13
  • CSTM 3
  • Target Price
  • IDYA $51.36
  • CSTM $18.00
  • AVG Volume (30 Days)
  • IDYA 1.1M
  • CSTM 1.5M
  • Earning Date
  • IDYA 08-05-2025
  • CSTM 07-29-2025
  • Dividend Yield
  • IDYA N/A
  • CSTM N/A
  • EPS Growth
  • IDYA N/A
  • CSTM N/A
  • EPS
  • IDYA N/A
  • CSTM 0.22
  • Revenue
  • IDYA $7,000,000.00
  • CSTM $7,605,000,000.00
  • Revenue This Year
  • IDYA $101.44
  • CSTM $5.41
  • Revenue Next Year
  • IDYA $263.37
  • CSTM $8.46
  • P/E Ratio
  • IDYA N/A
  • CSTM $62.76
  • Revenue Growth
  • IDYA N/A
  • CSTM 2.04
  • 52 Week Low
  • IDYA $13.45
  • CSTM $7.33
  • 52 Week High
  • IDYA $40.74
  • CSTM $17.27
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 52.57
  • CSTM 51.13
  • Support Level
  • IDYA $22.09
  • CSTM $13.06
  • Resistance Level
  • IDYA $24.75
  • CSTM $14.40
  • Average True Range (ATR)
  • IDYA 1.25
  • CSTM 0.59
  • MACD
  • IDYA -0.13
  • CSTM -0.01
  • Stochastic Oscillator
  • IDYA 40.05
  • CSTM 31.38

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

Share on Social Networks: